Introduction
============

The sinoatrial (SA) node, the primary physiological pacemaker of the heart, drives more than 3 billion heartbeats during a human life span. The SA node automaticity is generated within the SA node pacemaker cells (SANCs), which fire spontaneous action potentials (APs) because of gradual depolarization of the membrane potential called diastolic depolarization (DD) linked to complex interactions of 'coupled clock' mechanisms. The 'membrane clock' refers to multiple voltage-gated ion channels and transporters in the cell membrane, including hyperpolarization-activated "funny" current I~f~, L-type and T-type Ca^2+^ currents (I~Ca,L~ and I~Ca,T~), delayed rectifier potassium current (I~K~), Na^+^/Ca^2+^ exchange current (I~NCX~), Na^+^/K^+^ exchange current (I~NaK~), etc. (**Figures [1A,B](#F1){ref-type="fig"}**; [@B21]; [@B46]).

![A schematic illustration of regulation of the basal cardiac pacemaker function by PDEs and PKA-dependent phosphorylation in intact SANC. **(A)** The coupled-clock pacemaker system. Intracellular SR Ca^2+^ cycling (in red) operates in conjunction with the ensemble of membrane ion channels on a beat-to-beat basis. Note that L-type Ca^2+^ channel and I~NCX~ current are both Ca^2+^ cycling proteins and surface membrane currents. Constitutive activation of the basal AC activity results in an elevated level of cAMP and cAMP/PKA-dependent phosphorylation, which is kept in check by a high basal PDE activity. The PKA-dependent phosphorylation modulates function of Ca^2+^ cycling proteins (PLB, RyR, L-type Ca^2+^ channel, NCX current). **(B)** Schematic illustration of spontaneous SANC APs, Ca^2+^ transients, LCRs, and several major ion currents involved in generation of the DD. The LCR-induced increase in local \[Ca^2+^\] beneath the sarcolemma activates an inward NCX current creating exponential increase in the DD rate (Non-linear DD). See text for additional details. **(C)** Comparison of relative changes in the spontaneous SANC beating rate produced by selective inhibitors of PDE1-PDE4 alone or in combination and expressed as % of control. One-way ANOVA with Tukey *post hoc* test, ^∗^*P* \< 0.05 vs. PDE3 + PDE4 or All PDEs inhibition. **(D)** Distribution of PDE3 and PDE4 activities in SR-enriched and cytosolic fractions in rabbit SA node \[modified from [@B62]\]. **(E)** Average changes in PLB phosphorylation at Ser^16^ site in rabbit SANC by cilostamide (0.3 μmol/L) or rolipram (2 μmol/L) alone, combination of cilostamide + rolipram or 100 μmol/L IBMX expressed as % of control (*n* = 7--9 rabbits). One-way ANOVA with Tukey *post hoc* test, ^∗^*P* \< 0.05 vs. cilostamide or rolipram alone. **(F)** Regulation of L-type Ca^2+^ current amplitude by dual PDE3 + PDE4 activation; average increases in I~Ca,L~ amplitude during inhibition of PDE3 or PDE4 alone, concurrent PDE3 + PDE4 inhibition, or IBMX presented as % of control (*n* = 5--7 SANC). One-way ANOVA with Bonferroni *post hoc* test ^∗^*P* \< 0.01 vs. rolipram alone; ^+^*P* \< 0.01 vs. cilostamide alone. **(C,E,F)** Modified from [@B73], [@B72]).](fphys-09-01301-g001){#F1}

Like other cardiac cells, SANCs have the sarcoplasmic reticulum (SR) and are equipped to cycle Ca^2+^ via sarco/endoplasmic reticulum Ca^2+^-ATPase (SERCA2) and Ca^2+^ release channels, ryanodine receptors (RyRs). The SANCs can generate spontaneous local Ca^2+^ releases (LCRs) from RyR in the subsarcolemmal space during late DD before the AP upstroke (**Figures [1A,B](#F1){ref-type="fig"}**; [@B7]). Numerous studies have confirmed the presence of rhythmic LCRs under normal physiological conditions in SANCs of different species ([@B18]; [@B38]; [@B74]; [@B24]; [@B77]; [@B64]). The LCRs activate an inward I~NCX~, which exponentially accelerates the rate of DD, prompting the "Membrane clock" to generate the next AP ([@B7]; [@B57]; [@B32]). Colocalization of Na^+^/Ca^2+^ exchanger (NCX) and RyRs in rabbit SANC ([@B42]) permits a quick conversion of LCRs beneath the sarcolemma into changes in the inward current that depolarizes the membrane potential. The SR-generated LCRs can occur independent of concurrent changes in the membrane potential; they persist during the voltage clamp of the cell membrane or in permeabilized SANCs ([@B74]; [@B32]), manifesting the intracellular SR Ca^2+^ cycling "Ca^2+^ clock" in the absence of the "Membrane clock." The dynamic interaction of the "Ca^2+^ clock" and "Membrane clock" permits a high level of mutual entrainment between two individual clocks on a beat-to-beat basis (**Figures [1A,B](#F1){ref-type="fig"}**). This clock entrainment provides an additional degree of flexibility and robustness to the generation of spontaneous APs by the cardiac pacemaker cells ([@B32]; [@B79]).

The cyclic adenosine monophosphate (cAMP) is a ubiquitous secondary messenger that modulates multiple cell processes, e.g., cAMP-mediated protein kinase A (PKA)-dependent protein phosphorylation. Basal level of cAMP in rabbit SANCs is substantially higher than in ventricular myocytes (VM) ([@B71]; [@B80]; [@B32]) due to constitutive activation of adenylyl cyclases (ACs). This basal AC activity is independent of constitutive β-adrenergic receptor (β-AR) activation, since neither the β1-AR antagonist, CGP-20712A, nor the β2-AR inverse agonist, ICI 118,551 affect the spontaneous SANCs beating rate ([@B71]; [@B32]). Both the "Membrane clock" and "Ca^2+^ clock" are regulated by cAMP and cAMP-mediated PKA-dependent phosphorylation. Funny current is directly activated by cAMP ([@B10]; [@B68]). Several ion currents in SANCs are targets of the PKA-dependent phosphorylation including I~Ca,L~, I~K~, I~f~, etc. ([@B21]; [@B46]; [@B37]). Proteins involved in the intracellular SR Ca^2+^ cycling in SANC \[i.e., phospholamban (PLB), RyR, and SERCA\] are also regulated by PKA-dependent phosphorylation ([@B71]; [@B32]). The generation of rhythmic spontaneous LCRs and basal spontaneous firing of SANCs require a high basal level of cAMP and cAMP-mediated PKA-dependent phosphorylation ([@B71]; [@B32]).

The cell cAMP level is the result of a balance between cAMP production by ACs and its degradation into 5′-AMP by cyclic nucleotide phosphodiesterases (PDEs), the only known mechanism to degrade cAMP ([@B3]). The PDE superfamily contains 11 distinct gene families (PDEs 1--11), and at least four PDE families (PDE1-PDE4) can hydrolyze cAMP in the heart. Specifically, PDE1 is activated by Ca^2+^/calmodulin, PDE2 is stimulated by cGMP, PDE3 is inhibited by cGMP, and PDE4 is specific for cAMP. The PDE3 and PDE4 represent the major cAMP PDE activities in cardiac myocytes ([@B70]; [@B76]; [@B50]).

The normal AP firing of rabbit SANC is regulated by basal PDE activation, and its inhibition by broad-spectrum PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX), markedly increases the level of cAMP and concurrently increases the spontaneous SANC firing rate by ∼50%, which surpasses the positive chronotropic effect of the β-AR agonist isoproterenol ([@B73]; **Figure [1C](#F1){ref-type="fig"}**). Combined activities of PDE3 and PDE4 represent the major basal PDE activities in the rabbit SA node, accounting for ∼50% in cytosolic and ∼90% in SR fractions (**Figure [1D](#F1){ref-type="fig"}**; [@B62]). A synergistic relationship between PDE3 and PDE4 inhibition has been noted in different cell types, including vascular smooth muscle cells ([@B53]), brown adipose tissue ([@B31]), and rat VM ([@B49]). Normal automaticity of rabbit SANC is regulated by dual PDE3 + PDE4 activation apparently operating in a synergistic manner ([@B72]).

This mini-review is focused upon how cAMP-degrading PDEs regulate the normal spontaneous beating rate of SANCs, including expression and distribution of different PDE subtypes within SANCs, specific targets, and mechanisms of PDE-dependent regulation of spontaneous SANC firing. Evidence for compartmentalization of cAMP signaling in cardiac pacemaker cells under basal conditions is also discussed.

Basal PDE Activity Controls Normal Spontaneous Firing of Cardiac Pacemaker Cells
================================================================================

Suppression of PDE activity in isolated SA node produces an increase in cAMP level ([@B61]), acceleration of DD rate, and increase in the spontaneous SA node beating rate of different species ([@B29]; [@B51]; [@B39]; [@B63]). The PDE3 is the most abundant PDE isoenzyme in the myocardial tissue of most mammalian species ([@B52]). Although PDE3 can hydrolyze both cAMP and cGMP, the catalytic rates for cAMP are 5--10-fold higher, than for cGMP, which makes PDE3 very efficient in degrading cAMP ([@B5]; [@B52]).

The PDE3 inhibition increases the spontaneous beating rate of the SA node in guinea pigs ([@B51]), rabbits ([@B26]), dogs ([@B58]), and humans ([@B22]). In the murine heart, PDE4 is the major PDE isoform and accounts for∼60% of the total cAMP hydrolyzing activity ([@B52]). Inhibition of either PDE3 or PDE4 increases the spontaneous beating of the mouse SANCs ([@B17]) or rat SA node ([@B26]).

The PDE1 is an abundant cytosolic PDE isoenzyme in human ventricular myocardium ([@B75]) or VM ([@B23]). Targets of PDE1-dependent regulation in VM, however, remain obscure, since inhibition of PDE1 activity produces a decrease rather than increase in contraction amplitude of human VM ([@B23]). Nimodipine-sensitive activity of PDE1, measured in lysates of isolated rabbit SANCs, accounted for ∼40% of total PDE activity ([@B41]), but PDE1 inhibition increased spontaneous firing of rabbit SANCs by ∼15% (**Figure [1C](#F1){ref-type="fig"}**). The PDE1 activity might have a greater impact at higher cAMP levels; indeed, stimulation of ACs with forskolin markedly increases both cAMP level and PDE1 activity in paced mouse VM ([@B65]).

Although average increases in the basal spontaneous beating rate of rabbit SANCs by inhibition of single cAMP-degrading PDEs (PDE1--PDE4) are relatively small (**Figure [1C](#F1){ref-type="fig"}**), concurrent inhibition of PDE3 + PDE4 increases the spontaneous SANC beating rate by ∼48% ([@B72]), creating an effect comparable with that of IBMX (**Figure [1C](#F1){ref-type="fig"}**). An acceleration of spontaneous SANC firing by concomitant PDE3 + PDE4 inhibition by ∼twofold exceeds the summed increases in the spontaneous firing produced by inhibition of PDE3 (∼20%) and PDE4 (∼5%) alone ([@B72]), indicating that the dual PDE3 + PDE4 activation operates synergistically to suppress basal spontaneous firing of rabbit SANCs ([@B72]).

Effects of PDE Inhibition on Protein Phosphorylation in SANC
============================================================

An increase in cAMP-mediated PKA-dependent phosphorylation of multiple proteins in cardiac cells occurs in response to PDE inhibition. Among Ca^2+^ cycling proteins phosphorylated in the basal state in rabbit SANC are PLB ([@B71]; [@B32]), RyRs ([@B36]), and likely L-type Ca^2+^ channels ([@B54]). PLB modulates kinetics of SR Ca^2+^ pumping: in unphosphorylated state PLB colocalizes with SERCA2 to inhibit its function to pump Ca^2+^ into SR ([@B43]). Phosphorylation of PLB by PKA at Ser^16^ site in VM relieves this inhibition elevating SERCA activity by ∼2--3-fold ([@B43]). Phosphorylation status of PLB at Ser^16^ site is a useful marker of PKA-dependent protein phosphorylation in SANC. Inhibition of either PDE3 or PDE4 alone produces only minor (∼20%, *P* \> 0.05) increase in PLB phosphorylation at Ser^16^ site in SANC, but dual PDE3 + PDE4 inhibition increases PLB phosphorylation by ∼110%, an effect comparable to that of IBMX (**Figure [1E](#F1){ref-type="fig"}**). Therefore, basal PLB phosphorylation at Ser^16^ site in SANC appeared to be regulated by synergism of concurrent PDE3 + PDE4 activation ([@B72]). This boost in basal PKA-dependent phosphorylation, produced by dual PDE3 + PDE4 inhibition and reflected in PLB phosphorylation, might also affect multiple other proteins involved in the regulation of cardiac pacemaker function which require further investigation.

Effects of PDE Inhibition on ionic Currents and SR Ca^2+^ Cycling in SANC
=========================================================================

The L-type Ca^2+^ channels are a well-known target of cAMP-mediated PKA-dependent pathway regulated by PDE activation. Comparable increases in basal I~Ca,L~ amplitude by ∼60 and ∼72% occur when PDE3 or PDE4 are inhibited in mouse SANC ([@B17]), consistent with an important role of basal PDE3 and PDE4 activity in the murine heart ([@B52]). Synergistic effect of dual PDE3 + PDE4 inhibition on I~Ca,L~ amplitude was observed both in human and rabbit atrial myocytes, creating effect comparable to that of IBMX. In contrast, PDE4 inhibition alone is without effect and PDE3 inhibition only moderately increases I~Ca,L~ amplitude in human and rabbit atrial myocytes ([@B25]). The PDE4 inhibition in rabbit SANC, as in human atrial myocytes, has no effect on I~Ca,L~ amplitude, while inhibition of PDE3 increases I~Ca,L~ by ∼60% (**Figure [1F](#F1){ref-type="fig"}**). Dual PDE3 + PDE4 inhibition increases I~Ca,L~ in rabbit SANC by ∼100%, markedly exceeding combined effects of separate PDE3 or PDE4 inhibition and creating effect comparable with that of IBMX (**Figure [1F](#F1){ref-type="fig"}**). Therefore, dual PDE3 + PDE4 activation regulates basal I~Ca,L~ amplitude in rabbit SANC in a synergistic manner ([@B72]).

Other ionic currents involved in the generation of DD are also regulated by PDEs, e.g., inhibition of PDE3 in rabbit SANC increases I~K~ and shifts voltage dependence of I~f~ activation to more positive potentials ([@B10]; [@B14]; [@B73]). In mouse SANC, inhibition of PDE activity by IBMX or PDE4 activity by rolopram shifts voltage dependence of I~f~ current to more positive potentials ([@B67]). The PDE3 inhibitor, milrinone, significantly increases I~f~ current amplitude by ∼20% ([@B66]) without shift of the voltage dependence of I~f~ current ([@B67]).

The LCRs are also regulated by basal PDE activation both in intact and permeabilized rabbit SANCs ([@B73], [@B72]; [@B32]). During each spontaneous cycle, AP-induced Ca^2+^ influx through L-type Ca^2+^ channels triggers global Ca^2+^ transient, depleting SR Ca^2+^, resetting the "Ca^2+^ clock," and leading to LCR termination. When the SR Ca^2+^ content is refilled by SERCA, LCRs start to occur, and the time from AP-induced Ca^2+^ transient to the onset of LCRs is the LCR period (**Figure [1B](#F1){ref-type="fig"}**). An increase in cAMP-mediated PKA-dependent phosphorylation of Ca^2+^ cycling proteins concurrently elevates amount of Ca^2+^ (influx via I~CaL~) available for pumping into SR, accelerates the SR Ca^2+^ refilling (PLB), and likely alters the threshold for spontaneous Ca^2+^ releases (RyR), creating conditions required to boost spontaneous LCRs and speed up their appearance.

In intact rabbit, SANCs inhibition of PDE3 markedly increases the LCR size and number per each spontaneous cycle by ∼20% each (*P* \< 0.05) and decreases the LCR period by ∼15% (*P* \< 0.05), while changes in these parameters by rolipram are relatively small. Dual PDE3 + PDE4 inhibition, however, produces a synergistic effect and augments both the LCR size and number by ∼45% (*P* \< 0.01) each, as RyR activation becomes more synchronized via RyR recruitment and decreases the LCR period by ∼40% (*P* \< 0.01). An amplification of local RyR Ca^2+^ release activates augmented I~NCX~ at earlier times leading to an increase in the DD rate and spontaneous SANC beating rate ([@B72]).

The contribution of "funny" current in the acceleration of spontaneous SANC beating rate by dual PDE3 + PDE4 inhibition was assessed in the presence or absence of I~f~ current inhibitors. Suppression of I~f~ current by either ivabradine or Cs^+^ markedly decreased the spontaneous SANC beating rate. The positive chronotropic effect of dual PDE3 + PDE4 inhibition or IBMX, however, remained preserved even in the absence of I~f~ current ([@B72]), indicating that the I~f~ current was not indispensable for the positive chronotropic effect of dual PDE3 + PDE4 inhibition. This might be related to specific locations of I~f~ channels within lipid raft domains of rabbit SANC ([@B2]), which could provide spatial barriers shielding I~f~ channels from cAMP elevation produced by dual PDE3 + PDE4 inhibition.

In contrast, when RyR function is disabled by ryanodine, dual PDE3 + PDE4 inhibition failed to accelerate the DD rate or increase the spontaneous SANC beating rate ([@B72]), despite preserved increase of I~Ca,L~ and I~K~ amplitudes ([@B73]), indicating requirement of intact RyR function. Therefore, effects of PDE inhibition to increase function of ionic currents alone are not sufficient to increase the basal spontaneous SANC beating rate, which requires a link between PDE inhibition-induced increases in ionic currents and SR Ca^2+^ cycling within the coupled clock system (**Figures [1A,B](#F1){ref-type="fig"}**).

Though L-type Ca^2+^ channels or PLB and likely others are regulated by concurrent PDE3 + PDE4 activation in a synergistic manner (**Figure [1](#F1){ref-type="fig"}**), changes in global intracellular cAMP in SANC did not follow this pattern. Specifically, dual PDE3 + PDE4 inhibition in SANC lysates increases cAMP level by only ∼90% less than the effect produced by IBMX (∼160%) or the sum of cAMP elevations created by inhibition of either PDE3 (∼45%) or PDE4 (∼56%) alone (Lukyanenko, unpublished data). Therefore, an increase in the spontaneous SANC beating rate by dual PDE3 + PDE4 inhibition (**Figure [1C](#F1){ref-type="fig"}**) is not created by changes in global cAMP, but likely by changes in local cAMP levels produced in the vicinity of PLB or L-type Ca^2+^ channels (scheme in **Figure [2](#F2){ref-type="fig"}**) or RyR etc.

![Expression of cAMP-degrading PDEs at RNA and protein levels in the cardiac pacemaker and ventricle. Possible organization of PDE1A and major PDE3 and PDE4 subtypes within compartments in single rabbit SANC. **(A)** Relative expression of PDE-coding transcripts (mean ± SEM) in rabbit SANCs and VM; (*n* = 4--9); 1-way ANOVA with Tukey *post hoc* test, adjusted ^∗^*P* \< 0.05 (SANC vs. VM for each PDE subtype); ^+^*P* \< 0.05 (PDE subtypes in SANC vs. PDE3A or PDE4B); **(B)** Quantitative mRNA expression of PDE 2, 3, and 4 subtypes in mouse SA node, right atrium (RA) and right ventricle (RV). Expression of PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, and PDE4D are shown relative to GAPDH as (mean ± SEM); *n* = 5 SA node trials, 5 RA trials, and 3 RV trials; ^∗^*P* \< 0.05; ^+^*P* \< 0.001 by two way ANOVA with Tukey's *post hoc* test \[modified from [@B17]\]. **(C)** (left) average data (*n* = 8) of PDE1A, PDE3A, PDE4A, PDE4B, and PDE4D protein expression in the rabbit SA node compared with the left ventricle (LV = 100%), column statistics ^∗^*P* \< 0.05; (right) representative Western blots of major PDE subtypes in the rabbit SA node and left ventricle. **(D)** Double immunostaining for PDE3A, PDE4B, and superimposed images (inset shows magnification of the rectangular area in overlay); intensity plots (taken along the line in inset) show overlapping distribution of PDE3A with PDE4B beneath sarcolemma of SANC. **(E)** Double immunostaining for PDE3A, PDE4D, and merged images (inset shows magnification of the rectangular area in overlay); intensity plots (taken along the line in inset) display overlapping distribution of PDE3A with PDE4D along Z-lines in SANC. **(F)** Double immunostaining for PDE3A, PLB, and merged images (inset shows magnification of the rectangular area in overlay); intensity plots (taken along the line in inset) display overlapping distribution of PDE3A and PLB. **(G)** Double immunostaining for PDE1A, HCN4, and merged images. **(H)** A schematic of possible organization of compartmentalized signaling in rabbit SANC associated with L-type Ca^2+^ channels or PLB-dependent regulation of SR Ca^2+^ cycling. **(A,C--G)** modified from [@B72] and [@B41].](fphys-09-01301-g002){#F2}

Rabbit SANC lack t-tubular system, but they have considerable number of caveolae, flask-like invaginated lipid rafts containing caveolin, which could provide abundant physical boundaries for localized cAMP signaling. In rabbit SANCs, caveolae increase the surface plasma membrane by ∼115 and ∼30% in VM ([@B47]). A variety of signaling molecules could be targeted to caveolae, including GPCRs, ACs, and PKA ([@B55]; [@B80]; [@B6]). The subpopulation of L-type Ca^2+^ channels and HCN4 channels are also localized to caveolae ([@B2]; [@B13]). Caveolae have been identified as membrane subdomains that compartmentalize β-adrenergic receptor signaling and as negative regulators of cAMP accumulation in cardiac myocytes ([@B55]; [@B6]). Though activity of PDE3 and PDE4 in rabbit SA node has been measured (**Figure [1D](#F1){ref-type="fig"}**), there is no information on how much of that activity might be inside or outside of caveolae.

Evidence for Compartmentalized cAMP-PKA Signaling in VM
=======================================================

In VM, intracellular cAMP concentration in the basal conditions is close to 1 μmol/L, and this value is ∼10-fold higher during hormone or neurotransmitter activation ([@B20]; [@B8]; [@B30]). Multiple PDEs are expressed in each cell, with different affinities for cAMP: PDE3 in the range of 10--100 nmol/L ([@B45]), PDE4 in the range of 2--8 μmol/L ([@B56]), while affinity of PDE1A or PDE2 exceeds 10 μmol/L ([@B5]). Thus, cAMP is degraded over a wide range of concentrations and cells can maintain cAMP level at the physiological range both in the basal state or during hormone and neurotransmitter stimulation.

Because affinity of endogenous PKA for cAMP is in the range 100--300 nmol/L ([@B50]) and free diffusion of cAMP within the cell is relatively fast (∼200 μm^2^/s) ([@B59]), cAMP would rapidly spread, PKA would be fully activated under basal conditions, and hormones would not be able to produce any cAMP-mediated PKA-dependent functional responses. This controversy led to a hypothesis that PKA is compartmentalized in special domains with significantly lower basal cAMP level compared with that of the global cytosol ([@B19]). Therefore, intracellular pools of cAMP in the cell, their signaling pathways, and functional responses are spatially and functionally compartmentalized by PDEs, which rapidly degrade cAMP, providing functional barriers to cAMP diffusion ([@B5]; [@B16]; [@B12]; [@B27]; [@B9]). The PDEs might create local pools "microdomains" with high or low cAMP levels; in the latter case, PDEs act like "black holes" converting cAMP into 5′-AMP and thus, protecting specific compartments from cAMP influx and PKA activation ([@B9]; [@B48]).

Genetic manipulations of mice showed that both PDE3 and PDE4 may reside in the same localized compartments associated with either L-type Ca^2+^ channels or SR in VM. Indeed, PDE3A is colocalized with SERCA2-PLB-AKAP18 multiprotein complex or "signalosome" that regulates refilling of SR through modulation of PLB phosphorylation both in mouse and human VM ([@B1]). In the mouse heart, PDE4B is a part of the L-type Ca^2+^ channel complex and represents the major PDE isoform modulating I~Ca,L~ amplitude during β-AR stimulation ([@B35]). The PDE4D is incorporated in the SERCA2-PLB signaling complex in mouse VM ([@B28]), while PDE4D3 was integrated into SR-associated RyR2 complex ([@B34]).

Rna Abundance, Protein Expression, and Distribution of Different Pde Subtypes in Sanc
=====================================================================================

At the messenger RNA level, PDE3A, PDE4A, PDE4B, and PDE4D are the major cAMP-degrading PDE subtypes expressed in both rabbit SANC and VM ([@B72]). Expressions of PDE3A and PDE4B mRNA in rabbit SANC are comparable and exceed expression of other PDE subtypes (**Figure [2A](#F2){ref-type="fig"}**). Compared with PDE3 or PDE4, PDE1 mRNA in rabbit SANC is relatively low, but PDE1A transcript abundance in SANC surpasses that in VM by fourfold ([@B41]). Interestingly, mRNA transcripts for PDE2A, PDE3A, PDE4A, PDE4B, and PDE4D are comparably expressed in the mouse SA node (**Figure [2B](#F2){ref-type="fig"}**; [@B17]). Expression of PDE3A and PDE4A protein was less abundant in the rabbit SA node compared with the left ventricle; expression of PDE4B protein was similar in both tissues, while expression of PDE4D ([@B72]) and PDE1A protein ([@B41]) was significantly higher in the rabbit SA node than in ventricle (**Figure [2C](#F2){ref-type="fig"}**).

Very little is known about the distribution of major PDE subtypes within SANC. Recent studies established that PDE1A, PDE3A, and PDE4B are localized beneath the sarcolemma of rabbit SANC (**Figure [2](#F2){ref-type="fig"}**; [@B41]; [@B72]). Colocalization of PDE3A and PDE4B beneath the sarcolemma of rabbit SANC (**Figure [2D](#F2){ref-type="fig"}**) suggests that, like in the mouse heart, these PDE subtypes could work together limiting Ca^2+^ influx through L-type Ca^2+^ channels in a synergistic manner (**Figure [1F](#F1){ref-type="fig"}**). The PDE3A is also detected in a striated pattern and colocalizes with the *Z*-line associated protein α-actinin in rabbit SANC. Similar to human or mouse VM ([@B1]), PDE3A is colocalized with SERCA, PLB, and PDE4D in striated patterns inside SANCs ([@B72]; **Figure [2](#F2){ref-type="fig"}**). Colocalization of PDE3A and PDE4D with SERCA and PLB suggests that these PDE isoforms could likely regulate cAMP-mediated PKA-dependent phosphorylation of major SR proteins in SANC (**Figure [2](#F2){ref-type="fig"}**).

Synergistic Effects of Dual Pde3 + Pde4 Inhibition in Sanc Are Likely Executed at the Local Level
=================================================================================================

Though dual PDE3 and PDE4 inhibition could interact synergistically to modulate functional effects mediated by cAMP in multiple cell types, the mechanisms underlying these synergistic effects remain unclear. This synergistic effect could be based on colocalization and interaction of different PDE3 and PDE4 subtypes (**Figure [2](#F2){ref-type="fig"}**). Since PDE3 affinity is ∼10--100 nmol/L, it is likely that PDE3 is active and degrades cAMP in the basal state, while PDE4 remains dormant. An increase in local cAMP level by inhibition of PDE3 alone may increase cAMP to a range required for PDE4 activation, concurrently elevating PKA-dependent phosphorylation of PDE4, which is associated with 2--6-fold increase in PDE4 activity ([@B60]). Activation of PDE4 would lead to a more efficient degradation of cAMP, creating a PKA-mediated feedback loop to promote local cAMP degradation. Therefore, PDE3- and PDE4-dependent modulation of spontaneous beating of SANC can be self-adaptive, i.e., the full functional effect being achieved only when both PDE3 and PDE4 are concurrently inhibited, elevating local level of cAMP and PKA-dependent phosphorylation to their highest levels and leading to a full-sized synergistic functional response. Coordinated regulation of several targets (L-type Ca^2+^ channels, PLB, etc.) by synergistic dual PDE3 + PDE4 activation could be energetically beneficial, since slight variations in local cAMP levels at multiple locations could lead to substantial functional effects.

Recent studies demonstrated that physiologically relevant cAMP signals operate within the nanometer range, creating local cAMP nanodomains, while 'global cAMP' is less involved in functional responses ([@B69]). Computational models of cAMP signaling help to understand changes in cAMP activity at the local level in the subcellular compartments of cardiac cells. Models predict that low basal \[cAMP\] in caveolae is critically dependent on restricted cAMP diffusion between membrane compartments and cytosol ([@B19]). The cAMP gradients might be also shaped by enhanced PDE activity ([@B59]), as e.g., in rabbit SANC. Future numerical models might explain how specific patterns of different PDE3 and PDE4 subtype protein expressions in rabbit SANC could impact local and global cAMP levels and affect numerous players involved in generation of the cardiac pacemaker function.

Future Directions in Measurements of Local cAMP-PKA Signaling in SANC
=====================================================================

Though it is helpful to directly measure PDE activity using classical biochemical assays, this experimental approach lacks spatial resolution. Local degradation of cAMP produced by PDEs creates cAMP gradients and forms nanodomain organization of cellular signaling ([@B40]). Real-time imaging of changes in \[cAMP\] dynamics using fluorescence resonance energy transfer (FRET)-based reporters is a powerful tool to study local intracellular signaling events linked to PDE activity. Multiple FRET sensors have been constructed to image local changes in cAMP in living cells based mostly on interaction between pairs of green (GFP) and yellow (YFP) fluorescent proteins. Upon cAMP binding, the conformation of FRET sensor protein changes, leading to displacement of fluorophores and alteration of FRET signal. Though FRET imaging has enhanced our understanding of compartmentalized cAMP signaling in different cell types, i.e., cardiomyocytes, pancreatic-β cells, neuron, and cancer cells ([@B15]; [@B33]; [@B44]; [@B4]; [@B11]), employment of FRET in the cardiac pacemaking field has only recently begun to emerge ([@B79]). Exploration of local signaling in cardiac pacemaker cells using FRET sensors, however, is a challenging task, because expression of detectable level of FRET sensors requires a culture of SANC. Even a short-term culture markedly changes basal characteristics of rabbit SANC via significant decrease in the level of type 2 regulator of G-protein signaling (RGS2) that facilitates activation of the AC/cAMP/PKA pathway via G~i~ inhibition, leading to a diminished level of cAMP/PKA-dependent phosphorylation accompanied by a ∼50% decrease in spontaneous SANC firing rate ([@B78]). Furthermore, cultured SANCs lose their spindle shape and became spherical or spread out with more than three projections ([@B78]). Changes in the cell shape alter the surface-to-volume ratio and modify the local balance of cAMP synthesis and degradation ([@B59]). Because of substantial differences in the shape and basal cAMP-PKA signaling, changes in local cAMP levels recorded with FRET sensors in cultured SANCs might be different from those in freshly isolated SANC. Moreover, because cAMP levels in the vicinity of individual PDEs could be relatively low (∼100 nmol/L), it might be beyond detection by currently available FRET sensors ([@B30]). Recently developed AKAP79--CUTie FRET, however, shows some promise in this regard, and detects statistically significant changes of cAMP in the range of 100 nmol/L^-1^ μmol/L ([@B30]). In short, future studies that utilize advanced methods of local cAMP measurements are required to understand specific mechanisms of compartmentalized PDE-regulated signaling and synergism of dual PDE3 + PDE4 inhibition in cardiac pacemaker cells.
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